Anti-HIV1 gp120 Neutralizing Antibody (V3S-0622-YC228) (CAT#: V3S-0622-YC228)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Rhesus, which can specifically recognize HIV1 gp120. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Rhesus
Target Species Human Immunodeficiency Virus 1 (HIV1)
Immunogen Soluble gp140-F trimers
Affinity 8 nM for gp120, 1.9 nM for gp120 core, 6.4 nM for TriMut
Isotype IgG kappa

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; Neut
Application Notes The antibody is recommended for detection of HIV1 gp120 by ELISA, Neut assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target HIV1 gp120
Alternative Name HIV-1 envelope glycoprotein gp120; gp120; HIV-1 gp120; HIV-1
Research Area Infectious Disease
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry